BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 16503249)

  • 1. Clinical implications of apoptosis in ischemic myocardium.
    Scarabelli TM; Knight R; Stephanou A; Townsend P; Chen-Scarabelli C; Lawrence K; Gottlieb R; Latchman D; Narula J
    Curr Probl Cardiol; 2006 Mar; 31(3):181-264. PubMed ID: 16503249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STAT signalling in the heart and cardioprotection.
    Soond SM; Latchman DS; Stephanou A
    Expert Rev Mol Med; 2006 Jul; 8(15):1-16. PubMed ID: 16836797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated STAT-1 pathway in the myocardium as a novel therapeutic target in ischaemia/reperfusion injury.
    Stephanou A
    Eur Cytokine Netw; 2002; 13(4):401-3. PubMed ID: 12517719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial ischemia and reperfusion injury.
    Buja LM
    Cardiovasc Pathol; 2005; 14(4):170-5. PubMed ID: 16009313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of apoptosis in reperfusion injury.
    Eefting F; Rensing B; Wigman J; Pannekoek WJ; Liu WM; Cramer MJ; Lips DJ; Doevendans PA
    Cardiovasc Res; 2004 Feb; 61(3):414-26. PubMed ID: 14962473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
    Ferdinandy P; Schulz R; Baxter GF
    Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mechanisms of myocardial cell protection from ischemia/reperfusion injury and potential clinical implications].
    Lamendola P; Di Monaco A; Barone L; Pisanello C; Lanza GA; Crea F
    G Ital Cardiol (Rome); 2009 Jan; 10(1):28-36. PubMed ID: 19292017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological targets revealed by myocardial postconditioning.
    Burley DS; Baxter GF
    Curr Opin Pharmacol; 2009 Apr; 9(2):177-88. PubMed ID: 19109069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardioprotective action of urocortin in early pre- and postconditioning.
    Cserepes B; Jancsó G; Gasz B; Rácz B; Ferenc A; Benkó L; Borsiczky B; Kürthy M; Ferencz S; Lantos J; Gál J; Arató E; Miseta A; Wéber G; Róth E
    Ann N Y Acad Sci; 2007 Jan; 1095():228-39. PubMed ID: 17404036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of the transcription factor NF-kappaB in the cardiac cell].
    Hernández Gutiérrez S; Rojas del Castillo E
    Arch Cardiol Mex; 2005; 75(3):363-70. PubMed ID: 16294826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the JAK-STAT pathway in myocardial injury.
    Barry SP; Townsend PA; Latchman DS; Stephanou A
    Trends Mol Med; 2007 Feb; 13(2):82-9. PubMed ID: 17194625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (S)-1-(alpha-naphthylmethyl)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (CKD712) reduces rat myocardial apoptosis against ischemia and reperfusion injury by activation of phosphatidylinositol 3-kinase/Akt signaling and anti-inflammatory action in vivo.
    Jin YC; Lee YS; Kim YM; Seo HG; Lee JH; Kim HJ; Yun-Choi HS; Chang KC
    J Pharmacol Exp Ther; 2009 Aug; 330(2):440-8. PubMed ID: 19458286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to myocardial ischemia/reperfusion injury involves Bnip3 and autophagy.
    Hamacher-Brady A; Brady NR; Logue SE; Sayen MR; Jinno M; Kirshenbaum LA; Gottlieb RA; Gustafsson AB
    Cell Death Differ; 2007 Jan; 14(1):146-57. PubMed ID: 16645637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapamycin confers preconditioning-like protection against ischemia-reperfusion injury in isolated mouse heart and cardiomyocytes.
    Khan S; Salloum F; Das A; Xi L; Vetrovec GW; Kukreja RC
    J Mol Cell Cardiol; 2006 Aug; 41(2):256-64. PubMed ID: 16769083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ischemic but not mechanical preconditioning attenuates ischemia/reperfusion induced myocardial apoptosis in anaesthetized rabbits: the role of Bcl-2 family proteins and ERK1/2.
    Lazou A; Iliodromitis EK; Cieslak D; Voskarides K; Mousikos S; Bofilis E; Kremastinos DT
    Apoptosis; 2006 Dec; 11(12):2195-204. PubMed ID: 17051325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional and clinical repercussions of myocyte apoptosis in the multifaceted damage by ischemia/reperfusion injury: old and new concepts after 10 years of contributions.
    Scarabelli TM; Gottlieb RA
    Cell Death Differ; 2004 Dec; 11 Suppl 2():S144-52. PubMed ID: 15608693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial apoptosis and ischemic preconditioning.
    Zhao ZQ; Vinten-Johansen J
    Cardiovasc Res; 2002 Aug; 55(3):438-55. PubMed ID: 12160941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lidocaine protects from myocardial damage due to ischemia and reperfusion in mice by its antiapoptotic effects.
    Kaczmarek DJ; Herzog C; Larmann J; Gillmann HJ; Hildebrand R; Schmitz M; Westermann A; Harendza T; Werdehausen R; Osthaus AW; Echtermeyer F; Hahnenkamp K; Wollert KC; Theilmeier G
    Anesthesiology; 2009 May; 110(5):1041-9. PubMed ID: 19352171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of autophagy in the heart.
    Nishida K; Kyoi S; Yamaguchi O; Sadoshima J; Otsu K
    Cell Death Differ; 2009 Jan; 16(1):31-8. PubMed ID: 19008922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-apoptotic role for C1 inhibitor in ischemia/reperfusion-induced myocardial cell injury.
    Fu J; Lin G; Wu Z; Ceng B; Wu Y; Liang G; Qin G; Li J; Chiu I; Liu D
    Biochem Biophys Res Commun; 2006 Oct; 349(2):504-12. PubMed ID: 16942749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.